ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, today unveiled its vision for highly ...
A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain potency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback